Examining mental health and reducing stigma in diabetes

Researchers are working to shed light on the psychosocial toll of living with diabetes

8:25 AM

Author | Molly Dwyer-White

finger pointing at person
Getty Images

According to the Centers for Disease Control and Prevention, diabetes affects over 37 million people in the United States alone.

And mental health and stigma around the condition have been a serious issue.

Michigan Medicine researchers have been working to improve these psychosocial concerns related to diabetes through the Caswell Diabetes Institute, which often pose issues for people living with the condition. 

Research with a purpose | Michigan Medicine

Mental health help in diabetes

The Diabetes Mental Health Initiative, led by Briana Mezuk, Ph.D., an associate professor in the Department of Epidemiology at the U-M School of Public Health, helps ensure support is provided to the whole person – physical, spiritual, and emotional.

With regular input from patients and families, this initiative aims to improve access to and delivery of psychosocial support while creating a global hub designed to lead research, training and dissemination of best practices for addressing the emotional and mental health of persons living with diabetes across the lifespan.

Connected work by Kevin Joiner, Ph.D., R.N., an assistant professor in the Department of Health Behavior and Biological Sciences of the U-M School of Nursing, is also aiming to reduce diabetes stigma for patients.

Advancing stigma-related research in diabetes

While the physical challenges of diabetes are well-documented, the toll taken by stereotypes and myths about diabetes is often overlooked.

People with diabetes may face negative and irrational attitudes, behaviors, and judgments about their condition. This “stigma” can manifest in various ways, including people with diabetes experiencing societal discrimination in addition to negative feelings and thoughts about themselves due to their disease.

Many times when talking about my research, others will share a story about their own experience -or that of a loved one- and what they believe to be diabetes stigma."

 – Kevin Joiner, PhD, RN

For those living with diabetes, these negative emotions and experiences are more common than might be realized.

“Many times when talking about my research, others will share a story about their own experience -or that of a loved one- and what they believe to be diabetes stigma,” Joiner said

Joiner is part of an international collaborative effort that’s underway to stand up this diabetes stigma by galvanizing support across multiple sectors of society, including health care, industry, families and communities.

Joiner and his team have developed and published a Spanish-language translation of the Type 2 Diabetes Stigma Assessment Scale (DSAS-2), a patient self-administered questionnaire for measuring diabetes stigma.

Using a simulated clinic environment through the HomeLab, the team is also piloting an intervention for healthcare providers who can play an important role in reducing diabetes stigma by being mindful of how some words can have negative meanings for people with diabetes and intentionally choosing words that are empowering.

These efforts, along with others, are prime examples of U-M research driving evidence-based patient-centered care and increasing support and resources for people living with diabetes.

If you are a healthcare provider in primary care and interested in being a part of this research, please take this self-guided screener or call 734-680-7864.

This work is part of the  Caswell Diabetes Institute, formed at the University of Michigan. The Caswell Diabetes Institute is working to discover and implement methods to prevent, treat, and cure diabetes, obesity, and related metabolic diseases and complications. The institute is working to elevate the voices of individuals with diabetes and their families in ways that ensure clinical and research efforts are closely aligned to improve health outcomes and quality of life.


More Articles About: Diabetes Diabetes Counseling Diabetes Education Diabetes Management Diabetes Support Metabolism, Endocrinology & Diabetes Type 1 Diabetes type 2 diabetes
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Microscope
Health Lab
Nerve damage reduced in prediabetic mice with diet, exercise
A low calorie diet and high intensity exercise can reduce nerve damage in prediabetic mice, according to a Michigan Medicine study.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Growing numbers of diabetic retinopathy in kids
Research highlights alarming rates of diabetic retinopathy; an ophthalmologist shares what to know.
eye flashlight in exam close up of woman's eye
Health Lab
Diabetic retinopathy is being diagnosed more in younger patients
Although previously rare in young people with diabetes, an editorial in JAMA Ophthalmology notes that diabetic retinopathy is increasing in younger patients, urging clinicians to remain vigilant of symptoms.
holding syringe white shirt close up in hands
Health Lab
Could GLP1RA drugs lower high iron levels?
GLP1RA drugs are used to treat obesity as well as type 2 diabetes. Research from University of Michigan Health finds that these drugs can also be effective in treating high iron levels, a cause and symptom of type 2 diabetes.
pill bottle spilling yellow blue
Health Lab
Drug used for alcoholism shows potential for stopping inflammatory disease
A study shows that disulfiram, known for causing severe hangover symptoms by blocking alcohol breakdown, also inhibits the inflammatory NLRP3 complex.
hands holding syringe white
Health Lab
How do GLP-1 weight loss drugs affect the liver?
Glucagon-like peptide-1, or GLP-1, receptor agonists, that aid in weight loss, are now being investigated for their ability to help other patients, including those with liver disease. However, a research letter discusses the first known case of hepatitis and jaundice in a patient taking these drugs.